Workflow
从养老到享老,北京已出台百项措施
Bei Jing Shang Bao·2025-09-14 16:57

Group 1 - The core viewpoint is that China's rapid aging population has become a national strategy, with Beijing implementing nearly a hundred special policies to transition from "elderly care" to "enjoying old age" and from basic security to quality enhancement [2] - Currently, 1 in 4 people in China is an elderly person, totaling 310 million, which accounts for 22% of the population, while in Beijing, 1 in 3 registered residents is an elderly person, making up 30% [2] - The "14th Five-Year Plan" emphasizes the development of elderly human resources and the silver economy, which is crucial for the well-being of millions of elderly people and for optimizing economic structure [2] Group 2 - The silver economy shows significant potential, covering eight key areas such as smart elderly care, elderly education, and health management, with a projected scale of approximately 7 trillion yuan in 2023, accounting for 6% of GDP, and expected to exceed 30 trillion yuan by 2035, reaching 10% of GDP [3] - The integration of digital technology and the health industry is reshaping the industry ecosystem, with smart health monitoring devices and AI-assisted diagnosis playing a crucial role in addressing the supply-demand imbalance in elderly health services [3] - The Ministry of Industry and Information Technology and the Ministry of Civil Affairs are promoting the use of robots in elderly care, with the smart service robot market expected to reach 50 to 100 billion yuan by 2025-2027 [3] Group 3 - The penetration rate of smart elderly care products is only 3.8% within the 7 trillion yuan silver economy, indicating a significant opportunity for industry growth [4] - The silver economy is viewed as both a business opportunity and a social responsibility, requiring policy guidance, market participation, and technological innovation to create a safe and friendly environment for the elderly [4] - The essence of the silver economy is human-centered, focusing on maximizing quality of life at minimal cost, and promoting a shift from "treating existing diseases" to "preventing future diseases" [4]